Detalhe da pesquisa
1.
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.
J Hepatol
; 75(3): 572-581, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34033851
2.
Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom.
Clin Gastroenterol Hepatol
; 19(4): 768-776.e10, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32562892
3.
Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581].
J Hepatol
; 78(4): 883, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36639314
4.
Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581].
J Hepatol
; 76(2): 489, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895949
5.
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.
Lancet Gastroenterol Hepatol
; 3(9): 626-634, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30017646